Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 8/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.43 |
| ▸ | PIP4K2A | P48426 | 4/20 | 0.41 |
| ▸ | PIP4K2B | P78356 | 4/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.40 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.40 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.39 |
| ▸ | ITK | Q08881 | 3/20 | 0.39 |
| ▸ | BTK | Q06187 | 3/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | BLK | P51451 | 1/20 | 0.39 |
| ▸ | CDK7 | P50613 | 1/20 | 0.38 |
| ▸ | CCNH | P51946 | 1/20 | 0.38 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25737029 | 0.78 | PPARG (0.45) | FGFR1 | |
| SCHEMBL20764166 | 0.70 | CDK14 (0.47) | EGFRERBB2PIP4K2APIP4K2BBRD4 | |
| SCHEMBL16665103 | 0.70 | NMT1 (0.58) | EGFRPIP4K2APIP4K2BITK | |
| SCHEMBL13067824 | 0.69 | EGFR (0.47) | EGFRERBB2PIP4K2APIP4K2BKDR | |
| SCHEMBL13389249 | 0.69 | EGFR (0.55) | EGFRERBB2PIP4K2APIP4K2BITK | |
| SCHEMBL16095359 | 0.69 | MAOB (0.58) | EGFRERBB2PIP4K2APIP4K2BACKR3 | |
| SCHEMBL16095361 | 0.69 | MAOB (0.58) | EGFRERBB2PIP4K2APIP4K2BACKR3 | |
| SCHEMBL16665163 | 0.69 | ITK (0.64) | EGFRERBB2PIP4K2APIP4K2BACKR3 | |
| SCHEMBL23336402 | 0.68 | CDK14 (0.46) | EGFRERBB2PIP4K2APIP4K2BKDR | |
| SCHEMBL17141876 | 0.68 | PIP4K2A (0.50) | EGFRPIP4K2APIP4K2BITKJAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192904-A1 | BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF | THE BROAD INSTITUTE, INC. | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192904-A1 | BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF | ERBB2, ACP1, TK1 | EGFR 220/4885ERBB2 1/4885PIP4K2A 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.